phenanthridone and ovalbumin

phenanthridone has been researched along with ovalbumin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldinucci, A; Ballerini, C; Biagioli, T; Cavone, L; Chiarugi, A; Moroni, F1

Other Studies

1 other study(ies) available for phenanthridone and ovalbumin

ArticleYear
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:7

    Topics: Analysis of Variance; Animals; Antigen Presentation; Autoimmunity; Cell Movement; Cells, Cultured; Central Nervous System; Cytokines; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; Ovalbumin; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Recurrence; Severity of Illness Index; Th17 Cells; Time Factors

2011